Cannabis Science Inc. (CBIS) Financials Nov 14, 20
Post# of 250675

Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Cannabis Science Inc.
Fiscal year is September-August. All values CAD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue - - 0 0 0
Cost of Goods Sold (COGS) incl. D&A - - 0 0 0
COGS excluding D&A - - 0 0 0
Depreciation & Amortization Expense 0 0 0 0 0
Depreciation 0 0 0 0 0
Amortization of Intangibles 0 0 0 0 0
Gross Income - - 0 0 0
2009 2010 2011 2012 2013 5-year trend
SG&A Expense - - 233,789 163,598 142,842
Research & Development 0 0 0 0 0
Other SG&A - - 233,789 163,598 142,842
Other Operating Expense 33,387 148,288 0 0 0
Unusual Expense 0 0 405,236 0 1.61M
EBIT after Unusual Expense 0 0 (405,236) 0 (1.61M)
Non Operating Income/Expense 0 0 0 0 0
Non-Operating Interest Income 6,240 1,790 10,517 2,291 100
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense - - 1,259 2,334 0
Gross Interest Expense - - 1,259 2,334 0
Interest Capitalized 0 0 0 0 0
Pretax Income (27,147) (146,498) (629,767) (163,641) (1.76M)
Income Tax 0 0 0 9,806 (9,806)
Income Tax - Current Domestic - - 0 0 0
Income Tax - Current Foreign - - 0 0 0
Income Tax - Deferred Domestic - - 0 9,806 (9,806)
Income Tax - Deferred Foreign - - 0 0 0
Income Tax Credits - - 0 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (27,147) (146,498) (629,767) (173,447) (1.75M)
Minority Interest Expense 0 0 0 0 0
Net Income (27,147) (146,498) (629,767) (173,447) (1.75M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (27,147) (146,498) (629,767) (173,447) (1.75M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (27,147) (146,498) (629,767) (173,447) (1.75M)
EPS (Basic) () (0.01) (0.07) (0.02) (0.12)
Basic Shares Outstanding 10.67M 10.67M 9.65M 11.49M 14.11M
EPS (Diluted) () (0.01) (0.07) (0.02) (0.12)
Diluted Shares Outstanding 10.67M 10.67M 9.65M 11.49M 14.11M
EBITDA (33,387) (148,288) (233,789) (163,598) (142,842)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.

